SuperworthEcolab ECL
- Market cap
- $80.9B
- PE
- 38.7×
- 10y median 37.3×
- Forward PE
- 33.5×
- 10y median 33.3×
- Price to sales
- 4.8×
- EV/EBIT
- 29.5×
- Revenue, 12 months
- $16.8B
- +7% on a year ago
- Net margin
- 12.6%
- Free cash flow yield
- 2.3%
Ecolab trades at 38.7× trailing earnings, near its ten-year median. Revenue was $16.8B over the last twelve months, up 7% on a year earlier with a 13% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $4B+8% | $3.9B+7% | $3.8B+5% | $4B+4% | $4B+1% | $4B+2% | $3.7B−2% | $4B+1% | $4.2B+4% | $4.2B+5% | $4.1B+10% | $4.4B+10% | |
| Cost of revenue | $2.3B+2% | $2.3B+1% | $2.1B−4% | $2.2B−4% | $2.3B−3% | $2.3B−1% | $2.1B−3% | $2.2B−1% | $2.3B+2% | $2.3B+4% | $2.3B+11% | $2.5B+11% |
| Gross profit | $1.6B+18% | $1.7B+17% | $1.6B+19% | $1.7B+15% | $1.7B+7% | $1.7B+5% | $1.6B+1% | $1.8B+3% | $1.9B+7% | $1.8B+6% | $1.8B+8% | $1.9B+8% |
| SG&A | $1B+17% | $1B+12% | $1.1B+9% | $1.1B+6% | $1B+0% | $1.1B+2% | $1.1B−3% | $1.1B−1% | $1.1B+5% | $1.1B+1% | $1.1B+5% | $1.1B+7% |
| $566M+17% | $590M+48% | $517.9M+47% | $656.9M+36% | $1B+85% | $582.8M−1% | $555.3M+7% | $710.1M+8% | $760.2M−27% | $712M+22% | $622M+12% | $757.9M+7% | |
| Interest expense | −$74.3M+14% | −$70.4M+1% | −$71.6M−4% | −$78.8M+1% | −$70.4M−5% | −$61.7M−12% | −$58.3M−19% | −$63.2M−20% | −$55.3M−21% | −$64.3M+4% | −$72.7M+25% | −$73.1M+16% |
| Pre-tax income | $506.2M+23% | $537.5M+67% | $458.9M+58% | $590.7M+40% | $987.3M+95% | $534.3M−1% | $510M+11% | $659.9M+12% | $717.7M−27% | $660.3M+24% | $558.1M+9% | $693.6M+5% |
| $96.8M+61% | $126.7M+143% | $42.3M−19% | $95.7M+11% | $246.5M+155% | $54.8M−57% | $103.5M+145% | $131.4M+37% | $128M−48% | $91.7M+67% | $121.5M+17% | $154.9M+18% | |
| Net income | $404M+16% | $405.2M+53% | $412.1M+77% | $490.9M+49% | $736.5M+82% | $472.9M+17% | $402.5M−2% | $524.2M+7% | $585M−21% | $563.9M+19% | $432.6M+8% | $534.9M+2% |
| $1.41+17% | $1.41+52% | $1.43+74% | $1.71+49% | $2.58+83% | $1.65+17% | $1.41−1% | $1.84+8% | $2.05−21% | $1.98+20% | $1.52+8% | $1.90+3% | |
| 286.9M+0% | 286.8M+1% | 287.8M+1% | 287M+0% | 286M−0% | 286M−0% | 285.3M−1% | 285.4M−1% | 285.4M−0% | 284.9M−0% | 283.7M−1% | 282.2M−1% |
Gross profit: 73 periods, Q2 FY08 to Q2 FY26: not printed by the filing, worked out from its own lines.
Net income: 8 periods, Q2 FY20 to Q4 FY22: not printed by the filing, worked out from its own lines.
EPS, diluted: 7 periods, Q4 FY08 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 6 periods, Q4 FY08 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Estimates
Next earnings report: .
| Quarter | Revenue | Range | EPS | Range | Analysts |
|---|---|---|---|---|---|
| Q3 FY26 | $4.7B | $4.4B to $4.8B | $2.17 | $2.15 to $2.18 | 14 |
| Q4 FY26 | $4.7B | $4.4B to $4.9B | $2.20 | $2.18 to $2.24 | 13 |
| Q1 FY27 | $4.5B | $4.3B to $4.6B | $1.91 | $1.79 to $1.97 | 5 |
| Q2 FY27 | $4.8B | $4.6B to $5B | $2.33 | $2.18 to $2.40 | 5 |
| Q3 FY27 | $5B | $4.7B to $5.1B | $2.53 | $2.37 to $2.61 | 5 |
| Q4 FY27 | $5B | $4.8B to $5.2B | $2.59 | $2.42 to $2.67 | 5 |
| Q1 FY28 | $4.8B | $4.5B to $4.9B | $2.20 | $2.06 to $2.27 | 6 |
| Q2 FY28 | $5.1B | $4.9B to $5.3B | $2.67 | $2.50 to $2.76 | 6 |
Peers
Companies in Chemicals - Specialty nearest Ecolab's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| ECLEcolab | $80.9B | 38.7× | 37.3× | 33.5× | 4.8× | +7% | 12.6% |
| SHWSherwin-Williams | $81.8B | 31.1× | 33.3× | 26.3× | 3.4× | +6% | 11.0% |
| APDAir Products and Chemicals | $68.4B | n/m | 28.1× | 21.6× | 5.4× | +5% | −0.4% |
| LINLinde | $234.6B | 32.9× | 34.4× | 27.2× | 6.6× | +7% | 20.4% |
| PPGPPG Industries | $24.6B | 15.8× | 24.0× | 13.4× | 1.5× | +5% | 9.6% |
| IFFInternational Flavors & Fragrances | $24B | 82.6× | 35.5× | 27.3× | 2.4× | −5% | 2.9% |
| LYBLyondellBasell Industries | $21.5B | n/m | 9.2× | 9.2× | 0.7× | −2% | −1.1% |
| RPMRPM International | $12.6B | 18.3× | 25.5× | n/m | 1.6× | +6% | 8.7% |
| CLXClorox | $10.4B | 17.9× | 26.3× | n/m | 1.6× | −5% | 8.7% |
| Peer median | $24.3B | 24.7× | 27.2× | 23.9× | 2.0× | +5% | 8.7% |
Investors who own it
Investors we follow who held Ecolab at the end of Jun 30, 2026, from their 13F filings.
- Tom GaynerMarkel Group0.6% of portfolio
- Baillie GiffordBaillie Gifford0.2% of portfolioadded
More on Ecolab
Each number over time
- PE ratio
- Forward PE
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Dividend yield
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #4of 27Specialty chemicals stocks with the highest profit margins
- #7of 29Specialty chemicals stocks with the fastest revenue growth
- #8of 21Materials stocks with the fastest expected revenue growth
- #8of 12Specialty chemicals stocks with the fastest earnings growth
- #10of 13Specialty chemicals stocks cheapest against their own PE history
Its groups
About
- Industry
- Chemicals - Specialty
- Sector
- Basic Materials
Valuation data, not investment advice. Prices as of .